MYD88 and myelodysplastic syndrome: Another key finding of this study is that blockage of MYD88 and downstream IL8 in MDS CD34+ cells, particularly in CD34+ cells isolated from patients with lower-risk MDS (IPSS low-risk and intermediate-1), could positively regulate differentiation of the erythroid lineage.